TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28347184

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study: 24708386

Group type: EXPERIMENTAL
Intervention: Group feedback condition (n = 137)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) condition (n = 126)
Number of subjects: 263
Study: 23910714

Group type: EXPERIMENTAL
Intervention: Phaco-chop
Number of subjects: 3

Group type: COMPARATOR
Intervention: Divide-and-conquer
Number of subjects: 3

Group type: COMPARATOR
Intervention: Stop-and-chop
Number of subjects: 3
Study: 21365307

Group type: EXPERIMENTAL
Intervention: Biofeedback technique using RESPeRATE™ device
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no biofeedback)
Number of subjects: 81
Study: 18515454

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) using a gelatin-based protein drink
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo condition (neutral tryptophan levels)
Number of subjects: 16
Study: 17566314

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/40 mg/day
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/20 mg/day
Number of subjects: 812

Group type: COMPARATOR
Intervention: Amlodipine 10 mg/day (monotherapy)
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril 10/40 mg/day and 10/20 mg/day
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril combinations
Number of subjects: 812
Study: 14732240

Group type: EXPERIMENTAL
Intervention: Ammonium sulphate fertiliser ((NH(4))(2)SO(4))
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 4
Study: 11182396

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 128
Study: 9186989

Group type: EXPERIMENTAL
Intervention: Long-term corticosteroid treatment
Number of subjects: 149
Study: 1405532

Group type: EXPERIMENTAL
Intervention: Locus equations for children's production of stop + vowel tokens
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison to adult norms
Number of subjects: 16
Study: 3895381

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Novaluzid (10 ml seven times daily)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 31248384

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (CR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioural activation (BA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem solving (PS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation (RE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CR - BA - RE - PS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BA - CR - RE - PS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PS - GA - CR - RE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RE - PS - BA - CR
Number of subjects: 0
Study: 27893574

Group type: EXPERIMENTAL
Intervention: 1:1 PRBC/FFP transfusion strategy
Number of subjects: 45

Group type: COMPARATOR
Intervention: 4:1 PRBC/FFP transfusion strategy
Number of subjects: 45
Study: 25516019

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 10 sessions
Number of subjects: 0
Study: 22961466

Group type: EXPERIMENTAL
Intervention: Potentially Harmful Behaviors (PHB)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Exemplary Care (EC)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Caregiving Stressors (daily care bother, behavioral bother, burden)
Number of subjects: 612
Study: 21457273

Group type: EXPERIMENTAL
Intervention: Masked sad facial expressions during an easy task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Masked happy facial expressions during a difficult task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Masked sad facial expressions during a difficult task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Masked happy facial expressions during an easy task
Number of subjects: 0
Study: 18208432

Group type: EXPERIMENTAL
Intervention: Double-bundle technique
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single intra-articular bundle plus extra-articular sling (Control)
Number of subjects: 72
Study: 16565618

Group type: EXPERIMENTAL
Intervention: CAregiver Sleep Intervention (CASI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control caregivers
Number of subjects: 30
Study: 14501025

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering treatment (statins)
Number of subjects: 98
Study: 10593621

Group type: COMPARATOR
Intervention: Placebo-treated patients with elevated depressive symptoms
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Greater social network contacts
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Lower social participation
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 671

Group type: COMPARATOR
Intervention: Cognitive-affective depressive symptoms in placebo-treated patients
Number of subjects: 671
Study: 8739113

Group type: EXPERIMENTAL
Intervention: m‐chlorophenylpiperazine (m‐CPP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L‐tryptophan (L‐TRP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: m‐CPP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L‐TRP
Number of subjects: 12
Study: 1948293

Group type: EXPERIMENTAL
Intervention: Interviewer assessment using the Disability Assessment Schedule (DAS II)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observer assessment using the Disability Assessment Schedule (DAS II)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Items related to social and cultural expectations on 'normal behaviour'
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Section 3 of the DAS
Number of subjects: 30
Study: 7034758

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine in 8% dextrose, 2 ml, 3 ml, or 4 ml
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine in 8% dextrose, 1.3 ml or 2 ml
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine in 8% dextrose, 3 ml
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both solutions (0.5% and 0.75%)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 57
Study: 31544376

Group type: EXPERIMENTAL
Intervention: Warm acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 90
Study: 29071848

Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granule
Number of subjects: 623

Group type: COMPARATOR
Intervention: Fufang Shuanghua granule
Number of subjects: 623
Study: 27057798

Group type: EXPERIMENTAL
Intervention: Proliposomal 4% ropivacaine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Plain 0.5% ropivacaine
Number of subjects: 15
Study: 25136017

Group type: EXPERIMENTAL
Intervention: KAF156 single dose (10 to 1,200 mg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: KAF156 multiple doses (60 to 600 mg once daily for 3 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: KAF156 (400 mg) under fed conditions
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: KAF156 (single and multiple doses)
Number of subjects: 70
Study: 22311907

Group type: COMPARATOR
Intervention: sFlt1 levels at 20 weeks' gestation
Number of subjects: 109

Group type: COMPARATOR
Intervention: sFlt1:placental growth factor ratio at 20 weeks' gestation
Number of subjects: 109

Group type: COMPARATOR
Intervention: sFlt1, soluble endoglin, and sFlt1:placental growth factor ratio at clinical diagnosis
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placental growth factor levels at clinical diagnosis
Number of subjects: 109
Study: 20633284

Group type: EXPERIMENTAL
Intervention: Surfactant (200 mg/kg/dose, 3 doses at 0, 12, and 36 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 17438344

Group type: EXPERIMENTAL
Intervention: Utrecht Coping Power Program (UCPP)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Care as usual (family therapy or behavior therapy)
Number of subjects: 77
Study: 15677866

Group type: EXPERIMENTAL
Intervention: Donepezil (5.87 mg/day, SD = 1.92)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Galantamine (14.81 mg/day, SD = 6.25)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Rivastigmine (6.41 mg/day, SD = 1.82)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Historical untreated group (1991-1996)
Number of subjects: 147
Study: 12797647

Group type: EXPERIMENTAL
Intervention: Valdecoxib 10 mg once a day for 4 weeks
Number of subjects: 0
Study: 9583851

Group type: EXPERIMENTAL
Intervention: Standard dose lipid (25-30% of total daily energy)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Low dose lipid (6-8% of total daily energy)
Number of subjects: 512
Study: 10327712

Group type: EXPERIMENTAL
Intervention: Spraying
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Housing improvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of spraying plus housing improvement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 1906102

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CV)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Crossover from CV to HFJV
Number of subjects: 144

Group type: COMPARATOR
Intervention: Crossover from HFJV to CV
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: HFJV
Number of subjects: 144

Group type: COMPARATOR
Intervention: CV
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 144
Study: 6337038

Group type: EXPERIMENTAL
Intervention: heparin 5000
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: heparin 2500
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: heparin 2500 and 0.5 mg dihydroergotamine (HDHE 2500)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: 0.5 mg dihydroergotamine (DHE)
Number of subjects: 660

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: DHE
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: HDHE 2500
Number of subjects: 660
Study: 30720339

Group type: EXPERIMENTAL
Intervention: Quality improvement collaborative intervention including interactive learning sessions, webinars, quality improvement coaching, and root cause analyses.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Quality improvement collaborative targeting diagnostic errors of elevated blood pressure, adolescent depression, and abnormal laboratory studies.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Quality improvement collaborative aimed at reducing diagnostic errors.
Number of subjects: 31
Study: 29889294

Group type: EXPERIMENTAL
Intervention: Epithelium-off corneal cross-linking (CXL)
Number of subjects: 93
Study: 25595934

Group type: EXPERIMENTAL
Intervention: XELOX/FOLFOX
Number of subjects: 0

Group type: COMPARATOR
Intervention: LV/5‐FU
Number of subjects: 0
Study: 23985432

Group type: EXPERIMENTAL
Intervention: DASH/SRD diet (target sodium, 50 mmol/2100 kcal) for 21 days
Number of subjects: 13
Study: 21985226

Group type: EXPERIMENTAL
Intervention: Physical coordination training (PCT)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural theory‐based training (CBTr)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Reference group (REF)
Number of subjects: 294
Study: 19225130

Group type: EXPERIMENTAL
Intervention: Soy intake and isoflavones
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Equol hypothesis
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Soy intake
Number of subjects: 250
Study: 16520153

Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 2000
Study: 15193477

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily from the day of embryo transfer until pregnancy test
Number of subjects: 1380

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 1380
Study: 10994153

Group type: EXPERIMENTAL
Intervention: myrtol standardized (4 x 300 mg, day 1‐14)
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: cefuroxime (2 x 250 mg daily for day 1‐6)
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: ambroxol (3 x 30 mg for day 1‐3, 2 x 30 mg for days 4‐14)
Number of subjects: 676

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 676
Study: 8635931

Group type: EXPERIMENTAL
Intervention: 9-10 Neutron Gy (NGy) plus 38 Photon Gy (PhGy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: 15 Neutron Gy (NGy) plus 18 Photon Gy (PhGy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: 9-10 Neutron Gy (NGy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: 15 Neutron Gy (NGy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Patients with initial PSA ≤ 10
Number of subjects: 151
Study: 1352521

Group type: EXPERIMENTAL
Intervention: Zotepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 6428905

Group type: EXPERIMENTAL
Intervention: bezafibrate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: fenofibrate
Number of subjects: 16
Study: 29564806

Group type: EXPERIMENTAL
Intervention: Accelerated cross-linking (5 min of continuous UVA irradiation at 18 mW/cm2)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional riboflavin-UVA-induced CXL (30 min of UVA irradiation at 3 mW/cm2)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both interventions (Accelerated and Conventional CXL)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional CXL
Number of subjects: 34
Study: 30210070

Group type: EXPERIMENTAL
Intervention: MitraClip (MC) treatment
Number of subjects: 3253
Study: 26520434

Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Rigid cystoscopy
Number of subjects: 104
Study: 24343788

Group type: EXPERIMENTAL
Intervention: Operated knees (after arthroscopic surgery)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control knees (asymptomatic non-operated contralateral knees)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Operated knees (T2 values of suprapatellar subcutaneous adipose tissue)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control knees (T2 values of suprapatellar subcutaneous adipose tissue)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Operated knees (T2 values of deep intermuscular adipose tissue)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control knees (T2 values of deep intermuscular adipose tissue)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: IFP T2 values ≤ 139 ms
Number of subjects: 8
Study: 22732113

Group type: EXPERIMENTAL
Intervention: Left-sided double-lumen tracheal tube (DLT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Single-lumen tracheal tube with Arndt® blocker
Number of subjects: 50
Study: 20847061

Group type: EXPERIMENTAL
Intervention: Alcohol consumption with same-sex partners
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Alcohol consumption with other-sex partners
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (general)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No alcohol consumption (control)
Number of subjects: 66
Study: 17585665

Group type: EXPERIMENTAL
Intervention: Acupuncture at cervical Jiaji (EX‐B 2), 20 min each session, once a day, 10 sessions per course.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Chinese herbs with modified Buzhong Yiqi Decoction, one dose each day, 10 doses per course.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Western medicine with bandazol, Dextran 40, Danshen tablet, and vitamin B12, 10 days per course.
Number of subjects: 90
Study: 16271221

Group type: EXPERIMENTAL
Intervention: low level C(2)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: high level C(2)
Number of subjects: 53

Group type: COMPARATOR
Intervention: C(0)
Number of subjects: 53
Study: 12167139

Group type: COMPARATOR
Intervention: Amitriptyline alone (group 1)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Amitriptyline combined with fluoxetine (group 2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison of final headache index between groups
Number of subjects: 39
Study: 10209075

Group type: EXPERIMENTAL
Intervention: Lisinopril, 20 mg/day (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 40
Study: 9456943

Group type: COMPARATOR
Intervention: Manual injection at 2 ml/sec (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Automatic injection at 2 ml/sec (Group 3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Automatic injection at 4 ml/sec (Group 4)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Automatic injection at 6 ml/sec (Group 5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall evaluation of large and small diameter vessels
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 50
Study: 2143045

Group type: EXPERIMENTAL
Intervention: Isradipine (0.5 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 334082

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride
Number of subjects: 8

Group type: COMPARATOR
Intervention: Chlorpheniramine maleate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 8
Study: 31141198

Group type: EXPERIMENTAL
Intervention: Immediate loading of two implants supporting a locator-retained mandibular overdenture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed loading of two implants supporting a locator-retained mandibular overdenture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (immediate and delayed loading)
Number of subjects: 30
Study: 30802391

Group type: EXPERIMENTAL
Intervention: Chronic hepatitis associated with pulmonary tuberculosis
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Chronic hepatitis C and B
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Alcoholic steatohepatitis
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Non-alcoholic steatohepatitis
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Medicinal hepatitis
Number of subjects: 1189
Study: 25832995

Group type: EXPERIMENTAL
Intervention: Low-dose (0.6 mg/kg body weight; maximum 60 mg) i.v. rt-PA
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Early intensive BP lowering (systolic target 130-140 mmHg)
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Standard-dose (0.9 mg/kg body weight; maximum 90 mg) i.v. rt-PA
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Guideline-recommended BP control (systolic target <180 mmHg)
Number of subjects: 2500
Study: 23525080

Group type: EXPERIMENTAL
Intervention: Non-viral, liposome-based gene therapy formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21457152

Group type: EXPERIMENTAL
Intervention: Sildenafil (0.5 mg.kg(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19494179

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 847
Study: 17110217

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.05 mg
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.1 mg
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Dutasteride 2.5 mg
Number of subjects: 416

Group type: COMPARATOR
Intervention: Finasteride 5 mg
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 15017453

Group type: EXPERIMENTAL
Intervention: Concrete Objective Information (COI)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Relaxation Instruction (RI)
Number of subjects: 76
Study: 11316141

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg b.i.d.
Number of subjects: 537

Group type: COMPARATOR
Intervention: Naproxen 500 mg b.i.d.
Number of subjects: 537
Study: 9135356

Group type: EXPERIMENTAL
Intervention: Scavenging system
Number of subjects: 40

Group type: COMPARATOR
Intervention: No scavenging system
Number of subjects: 40
Study: 8187254

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Epidural route
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous group
Number of subjects: 50
Study: 3605278

Group type: EXPERIMENTAL
Intervention: Limbal-based flap
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fornix-based flap
Number of subjects: 20
Study: 30122896

Group type: EXPERIMENTAL
Intervention: Leucostim® (5 μg/kg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Leucostim® (10 μg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Neupogen® (5 μg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Neupogen® (10 μg/kg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both products
Number of subjects: 56
Study: 27092674

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (individual lifestyle counseling, group workshop, group counseling in healthy lifestyles, environmental intervention)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 142
Study: 25531837

Group type: EXPERIMENTAL
Intervention: Classical music during TRUS-guided prostate biopsy
Number of subjects: 76
Study: 22607822

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 134537
Study: 19840137

Group type: EXPERIMENTAL
Intervention: PHQID hospitals (pay-for-performance program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-PHQID hospitals (control group)
Number of subjects: 0
Study: 18663723

Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5/15 mg once daily (o.d.)
Number of subjects: 716
Study: 15989122

Group type: EXPERIMENTAL
Intervention: Memory responses after removing veridical responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory blends for verbally quantified information
Number of subjects: 0